Dosing of Beta-Blocker Therapy Before, During, and After Hospitalization for Heart Failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure)
- 1 December 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 102 (11), 1524-1529
- https://doi.org/10.1016/j.amjcard.2008.07.045
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Influence of a Performance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart FailureArchives of Internal Medicine, 2007
- β-Blocker dosing in community-based treatment of heart failureAmerican Heart Journal, 2007
- Association Between Performance Measures and Clinical Outcomes for Patients Hospitalized With Heart FailureJAMA, 2007
- Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart FailureJAMA, 2006
- HFSA 2006 Comprehensive Heart Failure Practice Guideline: Introduction and Table of ContentsJournal of Cardiac Failure, 2006
- Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and designAmerican Heart Journal, 2004
- Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failureJournal of the American College of Cardiology, 2004
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- β-Blockers in Congestive Heart Failure: A Bayesian Meta-AnalysisAnnals of Internal Medicine, 2001
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996